ʻO Mildronate a me Riboxin nā lāʻau lapaʻau e hoʻomaikaʻi i nā kaʻina metabolic i loko o ke kino o ke kanaka. Hoʻohana nui ʻia nā lāʻau ʻelua i kēlā mau lāʻau lapaʻau e like me:
- cardiology
- neurology;
- nawai;
- lāʻau lapaʻau lāʻau.
Hoʻohui ʻia Mildronate
ʻO ka Mildronate kahi lāʻau lapaʻau e kuhikuhi ana i ka hoʻonuiʻana i nā kaʻina o ka hana o ka metabolism a me ka ikaika ma nā kiko. Hoʻohana lōʻihi ka hoʻohana ʻana i ka lāʻau i:
- hoʻonui hoʻonui hana;
- ka hōʻemi ʻana o nā hōʻike o ke kino a me ka noʻonoʻo;
- ka hana maʻamau o nā kaʻina metabolic myocardial;
- ka pōkole o ka hoʻihoʻi ʻana ma hope o ka hōʻeha ʻana o ka naʻau
- ka hoʻomaikaʻi ʻana i ka hāʻawi ʻana i ka oxygen i nā mea hoʻolaʻa a me kāna hoʻohana ʻana i ka maʻi artery coronary;
- ka hemo ʻana o nā pilikia a me nā autonomic o ka nūina ma ka hopena o ke kumu ʻalā.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina.png)
ʻO ka Mildronate kahi lāʻau lapaʻau e kuhikuhi ana i ka hoʻonuiʻana i nā kaʻina o ka hana o ka metabolism a me ka ikaika ma nā kiko.
Loaʻa ka Mildronate i nā ʻano 3:
- nā lāloʻi;
- ʻōiwi hoʻonā;
- papaomi.
ʻO ka hana nui o nā ʻano āpau ka meldonium. ʻO ka mea kōkua pūpū o ka hoʻonā wai ʻana i ka wai no ka injection. 'Furtherlelo hou aku nā kāpena i:
- kalaka ʻaʻa;
- stearate kalsiuma;
- silica;
- titanium dioxide;
- gelatin.
ʻO ka hoʻonohonoho ʻana o ka pākuhi i ka hoʻohui o ka mea hana e pili ana:
- wai maʻemaʻe;
- kinia cherry;
- glousin;
- Ethylene glycol.
Hiki i kahi papa o nā papa he 40 a 60 mau papa, he ʻāpana o ka hoʻonā i nā ʻōhua - 10 ampoule (5 ml). Loaʻa ka Syrup i nā hue wai o 100 a me 250 ml, kahi e hoʻohālikelike ʻia ai nā puna.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-2.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-3.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-4.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-5.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-6.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-7.jpg)
ʻO nā ʻōkuhi no ke koho ʻana iā Mildronate ʻo ia kahi mau maʻi a me nā ʻano o ke kino e like me:
- myocardial infarction a i ʻole pre-infarction kūlana;
- maʻi maʻi cardiovascular, komo me ka angina pectoris, ischemia, heart failed, myocardial dystrophy, etc.;
- maʻi kūmole a me ka haʻalele ʻana i nā hōʻailona;
- pilikia ulia cerebrovascular;
- hemorrous hemorrhage a i ʻole retina;
- maʻi maʻi pālia;
- ʻānō bronchitis a me nā palalā bronchial;
- poino a hypertonic a diabetes paha i nā moku o ka eyeball;
- luhi ʻo ke kino ma ke ʻano he maʻi lōʻihi, ke hoʻoikaika kino kino;
- luhi a me ka hoʻohaʻahaʻa i ka hana;
- hoʻomau i ke kaumaha.
Hoʻololi ka lōʻihi o ka mālama ʻana me Mildronate mai 1-2 mau wiki a hiki i 1.5-2 mau mahina a hilinaʻi ʻia i ka maʻi a me ka paʻakikī o ke ʻano o ka mea maʻi. No ka mea aia ka lāʻau i ke ʻano o nā lāʻau tonic, ua noi ia e lawe i ka hapa mua o ka lā (inā ʻaʻole hiki ke hoʻonāukiuki ka hiamoe). Lawe ʻia nā capsules i 1-2 mau manawa i ka lā, 500 mg (no kekahi mau maʻi a hiki i 1000 mg) hapalua hola i mua o kaʻai ʻana, eʻai ai i nā manawa he 2-4 mau lā ma kahi lā (1 scoop) hapalua hola ma mua o ka ʻai a i ʻole hapa hola ma hope o ka manawa.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-2.png)
Hoʻololi ka lōʻihi o ka mālama ʻana me Mildronate mai 1-2 mau wiki a hiki i 1.5-2 mau mahina a hilinaʻi ʻia i ka maʻi a me ka paʻakikī o ke ʻano o ka mea maʻi.
Hoʻokomo ʻia nā ʻōkuhi Mildronate ma loko. ʻO ka manawa pinepine, hāʻawi nā inikua i hoʻokahi manawa i ka lā ma 500 mg, akā i kekahi manawa, no ka laʻana, i ka mālama ʻana i ka lāʻau kūlohelohe, ʻelua papalua ka nui a me nā inikua. I ka mālama ʻana i nā maʻi hoʻoponopono ocular, ua mālama ʻia nā inikina parabulbularly (i loko o ka laha kikoo). ʻO ka lōʻihi loa o ka mālamaʻana he 10 mau lā.
ʻO nā hopena e lī pinepine ai e loaʻa:
- lie kanikela
- nā hana hōʻeha o ka hana o ke aʻeha o ka gastrointestinal (kaumaha i loko o ka'ōpū, dyspepsia, nausea);
- palpitations puʻuwai;
- kuolo;
- psychomotor agitation;
- lele i loko o ke koko;
- he allergy.
ʻAʻole i kuhikuhi ʻia ka Mildronate:
- hāpai a wahine a lactating;
- i ka mua o kēlā me kēia intolerance;
- nā kānaka e pilikia nei i ka hypertension intacranial;
- i ka ihu o ka maʻi ʻehā;
- keiki malalo o 12 makahiki.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-15.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-16.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-17.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-18.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-19.jpg)
Hoʻolaulau ʻo Riboxin
ʻO Riboxin kahi lāʻau lapaʻau kūwawa maʻalahi i hoʻolālā ʻia e hoʻomaikaʻi i ka metabolism myocardial, hoʻemi i ka wīwī o ka oxygen o nā io, a me ka hoʻomaʻamaʻa i ka naʻau mele.
Loaʻa i ka lāʻau lapaʻau he 2 mauʻano e hoʻokuʻu ai:
- ʻO nā pōpō
- hoʻonā wai hoʻonā.
ʻO ke kumu hana nui ma nā hihia ʻelua he inosine. ʻO nā mea kōkua i hana i ka papa papa:
- tīmaʻa cellulose;
- kalaka ʻaʻa;
- stearic acid;
- huehue
ʻO ka hoʻonohonoho o ka ʻōnaehana hoʻonā e hoʻohui ʻia:
- wai no kahi pona;
- hexamethylenetetramine;
- sodium hydroxide.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-3.png)
ʻO Riboxin kahi lāʻau lapaʻau kūwawa maʻalahi i hoʻolālā ʻia e hoʻomaikaʻi i ka metabolism myocardial, hoʻemi i ka wīwī o ka oxygen o nā io, a me ka hoʻomaʻamaʻa i ka naʻau mele.
Hana ka mea hana i nā papa i loko o nā pā o 50 pcs., A me nā ampoules (5 mg a me 10 mg) i nā pā o 10 pcs.
ʻO nā hana a ka lāʻau lapaʻau nui o Riboxin e loaʻa:
- ka hoʻomaikaʻi ʻana i ka helehelena coronary;
- ka ʻano maʻamau o ka ʻā ʻana o ka lau;
- ka hana ʻana o nā hana hoʻihoʻi i nā membous mucous o ka myocardium a me ka gastrointestinal tract;
- ka hoʻonui ʻana i ka ikehu o nā pilikia;
- hoʻomaikaʻi i ka hoʻoliʻi glucose;
- ka pale ʻana i ka hoʻopili ʻana o ka platelet i nā ʻōlelo nui;
- hoʻomaikaʻi i ka kōpiko koko;
- hoʻonui i nā kaʻina anabolic.
He lōʻihi nā papa inoa o ka Riboxin no ka hoʻohana ʻana, akā maʻamau ka mea i kuhikuhi ʻia i ka mālama ʻia ʻana o nā maʻi cardiovascular, ʻo ia hoʻi:
- ischemia;
- angina pectoris;
- kūlana ma hope o ka haunaele myocardial;
- nā hana maʻi i loko o ka ʻiʻo;
- kue ʻole ʻia o ka hoʻopuni coronary;
- arrhythmia cardiac o kekahi kumu;
- maʻi ʻeha (congenital a loaʻa paha);
- naʻau puʻuwai o nā ʻano kumu like ʻole;
- nā loli o ka dystrophic ma ka myocardium ma muli o nā pilikia o ka hormonal, nā kaumaha he nui, nā maʻi, nā maʻi hopuna a me ka endocrine paha;
- atherosclerosis o nā ʻehā coronary.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-25.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-26.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-27.jpg)
Kau ʻia ka lāʻau lapaʻau no nā ala ʻē aʻe, e like me:
- glaucoma wehe (hoʻohana i ka hana paʻakikī);
- urophorphyria;
- nā maʻi maʻi ʻeha (hepatitis, dystrophy parenchymal, cirrhosis);
- ka huila o ka puhā glycoside;
- poino a hōʻino paha i ka lāʻau kūpaʻa ma ke akea;
- ʻōpū o ka ʻōpū a me ka duodenum.
Hoʻomaopopo pinepine ʻia ka lāʻau lapaʻau no nā mea hoʻokūkū ʻoihana e hoʻonui i ka ikaika o ke kino i ka wā e hoʻomaʻamaʻa ana a me nā hoʻokūkū.
Aia kekahi mau contraindications i ka hoʻohana ʻana o Riboxin. ʻAʻole kuhikuhi ʻia ka lāʻau lapaʻau inā e pilikia ka mea maʻi:
- kūlia kekahi kanaka i kāna mau ʻāpana;
- diabetes mellitus;
- maʻi kino koʻikoʻi;
- kohola
- hoʻolika;
- nā hemahema enzyme.
ʻAʻole i kuhikuhi ʻia ʻo Riboxin i nā keiki ma lalo o nā makahiki he 3 mai ka makahiki a me nā makuahine hānai.
ʻO nā hopena ʻaoʻao i ka wā e lawe ʻole ai ʻo Riboxin i kahi ʻokoʻa loa a hiki ke hele mai i ke ʻano o ka:
- huu
- urticaria;
- ʻulaʻula ma ka wahi i ʻōlelo ʻia;
- hoonui i ka wa uric i loko o ke koko (ma kēia hihia, pono e hana pinepine i nā hoʻokolohua hoʻohana.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-31.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-32.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-33.jpg)
ʻAʻole pono e lawe ʻia ʻo Riboxin i ka manawa like me nā alkaloids, e like me i ka wā e launa pū ai nā mea kanu, insoluble substance form form. Hoʻemi ʻia ka hopena o Riboxin inā i lawe ʻia me ka Vitamin B6, caffeine, theophylline, a me nā immunosuppressants. ʻO ka hui hoʻomohala o Riboxin me nā metabolites cardiac, ma ke kū'ē aʻe, e hoʻomaikaʻi i ka hopena therapeutic.
Pono e lawe ʻia nā papa Riboxin ma mua o ka papa ʻaina a nānā i nā kaulike like ma waena o nā pona. ʻO ka hoʻomaka ʻana o ka lāʻau lapaʻau ʻo 0.6-0.8 g i kēlā me kēia lā, ʻo ia hoʻi ʻo 3-4 mau papa o 200 mg. Inā hoʻomanawanui maikaʻi ka mea maʻi i ka lāʻau lapaʻau, a laila e hoʻonui ʻia ka lāʻau lapaʻau ma o 2 mau manawa (2 mau papa 3-4 i ka lā).
ʻAʻole pono nā moʻo therapeutic lōʻihi e hoʻonui i nā papa he 12 i kēlā me kēia lā. Ma muli o ka maʻiʻana a me ke ʻano o ka mea maʻi, hiki ke hoʻomau ka mālama ʻana mai 1 a 3 mau mahina. ʻO ke kumu kākoʻo no nā mea hoʻokūkū e pono ʻole e pākuʻi ʻia 3 mau mahina.
Hoʻohana ʻia ka hoʻonāʻau ʻana ma ke ʻano o kahi puna, kahi hui ʻia me ka 250 ml o ka sodium chloride a me ka glucose. ʻO ka dosage hoʻomaka e 10 ml a lawelawe ʻia i ka manawa 1 i kēlā me kēia lā, a laila e hoʻonui ʻia ke ʻano i 20 ml a lawelawe ʻia ʻelua i ka lā. ʻO ka papa therapeutic ʻo 10-15 lā.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-37.jpg)
Hoʻohana ʻia ka hoʻonāʻau ʻana ma ke ʻano o kahi puna, kahi hui ʻia me ka 250 ml o ka sodium chloride a me ka glucose.
Hoʻohālikelike o Mildronate a me Riboxin
ʻOiai nā mea like, like ʻole ʻo Mildronate a me Riboxin i ka mea like.
Hoʻohālike
ʻO nā lāʻau lapaʻau ke ʻano like o ka hoʻokuʻu, nā hōʻailona like no ka hoʻohana a me nā contraindications, nā maʻi a me nā hoʻoponopono hoʻoponopono.
He aha nā meaʻokoʻa?
ʻO ke kumu o nā lāʻau lapaʻau nā mea ʻokoʻa ikaika e hōʻike hou ana iā lākou iho i ka mālama ʻana i nā maʻi like. E hana wikiwiki ana ʻo Mildronate a hāʻawi i ke hopena maikaʻi loa i nā hihia kahi e pono ai ka mālama ʻana. Hāʻawi ʻo Riboxin i kahi hopena kūpono me ka mālama lōʻihi loa a hiki ke hoʻohana ʻia no ka pale ʻana.
Aia ia ka hapa?
ʻO ke kumukūʻai o nā papa he 40 (250 mg i kēlā me kēia mea) i ka papaʻaina ʻo Mildronate ma Moscow e like me 300-330 mau rubles, 60 papa (500 mg i kēlā me kēia - 600-690 mau rubles, 10 ampoules (5 ml kēlā) - 450 mau rubles. ʻO ke kumukūʻai o 50 mau papa o Riboxin (200 mg i kēlā me kēia) hoʻololi ʻia mai 35 a 50 mau rubles, 10 ampoules (5 ml kēlā) - 30-40 mau rubles, 10 ampoules (10 ml kēlā) - 50-80 rubles.
![](http://img.diabetesentity.com/img/sayd-2020/1566/sravnenie-mildronata-i-riboksina-38.jpg)
ʻO ke kumu o nā lāʻau lapaʻau nā mea ʻokoʻa ikaika e hōʻike hou ana iā lākou iho i ka mālama ʻana i nā maʻi like.
ʻO wai ka mea maikaʻi - Mildronate a i ʻole Riboxin?
ʻO ka manaʻo o nā kauka e pili ana i ka lāʻau lapaʻau ka ʻoi aku ka maikaʻi - ua mahele ʻia ʻo Mildronate a i ʻole Riboxin.
No ka puuwai
Ke koho ʻana i kahi lāʻau lapaʻau, puka mai kēlā me kēia kauka mai kāna hana a me nā nānā. ʻO kahi hana koʻikoʻi no ke koho ʻana i kahi lāʻau lapaʻau e mālama ʻia e ka maʻi a ka maʻi maʻi a me ka nui o kona ʻano. Ma nā hihia kūkaʻi (no ka laʻana, me ka puʻuwai puʻuwai a i ʻole hōʻino ʻia ka puʻuwai hōʻokoʻa), ʻoi aku ka maikaʻi o ke kuhikuhi ʻana iā Mildronate. No ka mālamaʻana a me nā papa pale, kūpono ʻo Riboxin.
I nā haʻuki
Ma waena o nā mea pāʻani helehelena a me ka pūʻali koa, nona ka hana e koi ai i ka hoʻomanawanui kino, ua paʻa ʻo Mildronat i kāna kūlana. A ʻoi aku ka nui o nā mea hoʻoikaika kino a me nā mea hoʻoikaika aku e loaʻa iā Riboxin. ʻO ka meaʻoiaʻiʻo o ka inosine, e hoʻomaikaʻi ana i ka hana a nā steroid anabolic, e hoʻomaikaʻi ana i ka loaʻa ʻana o ka ʻiʻo a hoʻomaikaʻi i ke ʻano o ka ʻiʻo.
Nā Hōʻike Hoʻomaʻi
ʻO Maxim, 26 mau makahiki ʻo Nizhny Novgorod: "Ua komo wau i nā mea hana i nā mea hana haʻuki ʻoi aku ʻoi aku i ka makahiki 6. I ka wā ikaika e aʻo ai ma mua o ka hoʻokūkū, lawe mau wau i nā inikini a Riboxin no nā wiki he 2. ua emi iho la. "
ʻO Anna, 50 makahiki, ʻo Kursk: "Ua nui wau mau makahiki i ke kanulau mai o ka maʻi vegetative-vascular dystonia, ka mea i hōʻike iā ia i ka ʻano o ka asthenia a me ka maʻi kaumaha. Ma hope o ka mālama ʻana me Mildronate, ua pau nā maʻi, ua holomua koʻu ʻano, hoʻomaka wau e neʻe.
Nā loiloi a nā kauka e pili ana i ka Mildronate a me Riboxin
Alexander, 46 makahiki, cardiologist, 20 makahiki ʻike, Volgograd: "Riboxin he antihypoxant maikaʻi loa me ka uku haʻahaʻa. No nā makahiki he nui i kuhikuhi ʻia e au i nā mea hoʻokūkū a loaʻa wale kahi hopena maikaʻi. Ua nānā nō wau i ka hopena o ka lāʻau lapaʻau, ma ke kuhikuhi ʻana i nā mea maʻi i ka ʻōpū mālama mālama" . ^ E Ha yM.
ʻO Vitaliy, 42 mau makahiki, narcologist, 16 mau makahiki o ka ʻike, ʻo Moscow: "Ua mālama ʻo Mildronat me nā hōʻike he nui o ka lāʻau ʻona a me ka inu ʻona. . ^ E Ha yM.